Extramural Research Programs in the Neurosciences and Neurological Disorders
Active
- Assistance listing
- 93.853
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- 43,866 $45,545,088,435 in federal obligations
Program facts
- Assistance types
-
- Project Grant
- Cooperative Agreement
- Block Grant
- Treasury account
-
- 75-0886-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The National Institute of Neurological Disorders and Stroke (NINDS) within the Department of Health and Human Services National Institutes of Health funds extramural research in neuroscience and neurological disorders under Assistance Listing 93.853, with the most recent award dated February 26, 2027, at $50,114.
This program supports basic and translational neuroscience research investigating fundamental brain and nervous system structure and function, disease mechanisms in neurological disorders, and therapeutic development. The portfolio includes clinical trials evaluating novel therapeutics, fellowship training grants, and Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) initiatives. Peer review occurs through technical panels composed of scientific experts and the National Advisory Neurological Disorders and Stroke Council, with funded projects competing on merit basis.
The portfolio is overwhelmingly dominated by Project Grants, which comprise 94 percent of awards (41,121 awards), with smaller shares of Block Grants (4 percent) and Cooperative Agreements (2 percent). NINDS itself manages the vast majority of funding: the National Institute of Neurological Disorders and Stroke directly administered 13,611 awards totaling $31.25 billion in federal dollars obligated, while parent-level NIHNIH administered an additional 28,994 awards worth $12.7 billion, establishing NINDS dominance across the portfolio. Combined federal and non-federal dollars obligated reached $47.44 billion, indicating substantial institutional and recipient cost-sharing. Typical Project Grant awards cluster in the $35,000 to $85,000 range for recent postdoctoral fellowship and early-career awards, with some larger U24 and RM1 mechanism awards reaching $150,000 to $227,000.
Recent awards reflect the program's scope: projects investigating spinal cord injury and locomotor recovery, glioblastoma tumor microenvironment mechanisms, multiple sclerosis cognitive dysfunction, epilepsy sudden unexpected death mechanisms, motor cortex reaching control, vestibular balance circuits, epilepsy surgery candidate identification using machine learning, cerebrospinal fluid dynamics, meningeal fibroblast development, cerebellar motor planning, synaptic zinc signaling, stress-induced migraine mechanisms, and gene replacement therapy for lysosomal storage disease. The portfolio spans basic mechanistic studies through clinical neurobiology to applied therapeutics and device development.
Grant opportunities posted in recent months are predominantly forecasts of future solicitations, not currently open competitions. These include cooperative agreements for clinical trial networks (NeuroNEXT, StrokeNet, SIREN, Undiagnosed Diseases Network), BRAIN Initiative technology dissemination and clinical device studies, ALS expanded access protocols, and targeted research programs in Alzheimer's disease mechanisms, pain network genomics, and medical device optimization. The Academic Career Excellence (K32) award for postdoctoral scholars is currently open with a due date of July 12, 2029.
Objective and description
- Objective
(1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understan
- Description
The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease for all people.
Eligibility
- Applicant eligibility
Research Grants: Any public, private, nonprofit, or for-profit institution is eligible to apply. For-profit institutions are not eligible for Institutional National Research Service Awards but are eligible for Individual NRSAs. All proposals are reviewed for scientific merit, for evaluation of the qualifications of the investigators, for adequacy of the research environment, and for significance of the problem. Approved proposals compete for available funds. All Career Development Program awardees, with the exception of awardees of the Pathway to Independence Award (K99/R00), must be citizens or have been admitted to the United States for permanent residence. Candidates must be nominated for the program by a nonfederal public or private nonprofit institution located in the United States, its possessions or territories. To be eligible, postdoctoral NRSA trainees or fellows must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D. Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the entire research must be performed in the United States. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
- Beneficiary eligibility
Health professionals, graduate students, health professional students, scientists, and researchers.
- Uses of assistance
Research grants may be used to provide salaries, equipment, supplies, travel and other expenses for research. The grantee institution is obliged to expend grant funds prudently for the purposes stated in the application and award document. National Research Service Awards (NRSAs) are made directly to individuals for research training in specified biomedical shortage areas, or to institutions, to enable them to make NRSAs to individuals selected by them. Each individual who receives a NRSA may be obligated upon termination of the award to comply with service and payback provisions. Career Development Awards such as the Independent Scientist Awards (K02) provide support for newly independent scientists with health-related degrees who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers and facilitating their ability to obtain major NIH research awards. Mentored Clinical Research Scientist Development Awards (K08) provide support for clinically trained health professionals who need an additional period of sponsored research experience as a way to gain expertise in a research area new to the candidate or in an area that would demonstrably enhance the candidate's scientific career. The K01 and K22 Mentored Research Scientist Development Awards are used to promote diversity in neuroscience research and support an intensive supervised research career development experience for underrepresented, disabled or disadvantaged career neuroscientists. The Mentored Patient-Oriented Research Career Development Award (K23) provide support for a period of supervised study and research for clinically trained professionals who have the potential to develop into productive clinical investigators. SBIR and STTR Phase I grants (of approximately 6-months to 2 years in duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants (of approximately 1 to 3 years in duration) are for the continuation of the research efforts initiated in Phase I that are likely to result in commercial products or processes. Phase II funding is based on results of research initiated in Phase I, scientific and technical merit, and commercial potential of Phase II application. Grant funds may be expended only for the purpose stated in the application and award document. The NINDS participates in the NIH SBIR/STTR "fast track" and Phase IIB initiatives.
- Length and time phasing of assistance
Research grant awards are made for a 12-month period with recommendation of up to 4 years of additional support, with limited exceptions for longer duration awards. Career Program awards provide support for 3 to 5 years. Training Program awards are usually for a 12-month period with recommendation of additional support of up to a total of 5 years for predoctoral training and no more than 3 years for postdoctoral training. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. Method of awarding/releasing assistance: quarterly.
How to apply
- Preapplication coordination
Research grant applications that request $500,000 or more in direct costs in any yearly budget period will not be accepted unless the NINDS has agreed to accept the application prior to submission (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-004.html).
- Criteria for selecting proposals
The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) the soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) the degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and 8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.
- Award procedure
Research Grant, Training, Fellowship and SBIR/STTR applications are reviewed initially by technical panels, composed of scientific authorities, and by the National Advisory Neurological Disorders and Stroke Council composed of 18 leaders in medical science, education, and public affairs. Approved applications will compete on a merit basis for available funds. Formal award notices are transmitted to the grantee or awardee.
- Time to approval or disapproval
Research grants: Approximately 6 to 9 months. Career program: From 7 to 8 months. SBIR/STTR applications: Approximately 6 to 9 months. Institutional Training Grants: From 6 to 12 months.
- Renewals
By application and review in same manner as new applications. A P.I. should consult the specific NOFO to determine if a particular grant is renewable.
- Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute, and subsequently, the P.I. and applicant institution may appeal to the NINDS appeals officer. A description of the NIH Peer Review Appeal procedures is available on the NIH home page http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.
Grant opportunities
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Grant awards
Latest 10 of 43,866 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | The General Hospital Corporation | $1,309,596,942 | 3% |
| 2 | The Regents Of The University Of California. San Francisco | $1,204,076,115 | 3% |
| 3 | The Johns Hopkins University | $1,055,413,992 | 2% |
| 4 | The Trustees Of Columbia University In The City Of New York | $984,237,455 | 2% |
| 5 | The Leland Stanford Junior University | $861,794,155 | 2% |
| 6 | Regents Of The University Of Michigan | $860,692,721 | 2% |
| 7 | The Washington University | $858,642,954 | 2% |
| 8 | Yale Univ | $810,273,687 | 2% |
| 9 | The Trustees Of The University Of Pennsylvania | $805,579,030 | 2% |
| 10 | Northwestern University | $781,053,152 | 2% |
10 of 1,425 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $2,075,873,698 |
| FY2025 | $2,823,147,077 |
| FY2024 | $3,778,693,816 |
| FY2023 | $4,554,699,056 |
| FY2022 | $3,782,742,523 |
| FY2021 | $3,834,253,959 |
| FY2020 | $2,125,395,195 |
| FY2019 | $1,934,070,820 |
| FY2018 | $1,722,668,649 |
| FY2017 | $1,482,889,028 |
| FY2016 | $1,423,053,419 |
| FY2015 | $1,325,559,706 |
| FY2014 | $1,305,997,550 |
| FY2013 | $1,262,917,242 |
| FY2012 | $1,336,617,486 |
| FY2011 | $1,327,853,551 |
| FY2010 | $1,354,168,040 |
| FY2009 | $1,320,826,858 |
| FY2008 | $673,393,217 |
| FY2007 | $922,324,245 |
| FY2006 | $1,151,418,991 |
| FY2005 | $1,230,766,604 |
| FY2004 | $1,203,244,842 |
| FY2003 | $1,172,241,672 |
| FY2002 | $1,151,208,668 |
| FY2001 | $318,356,878 |
Show all 26
Quick answers
What is Assistance Listing 93.853?
Assistance Listing 93.853 is Extramural Research Programs in the Neurosciences and Neurological Disorders, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Extramural Research Programs in the Neurosciences and Neurological Disorders?
Its CFDA number is 93.853: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.853 awarded?
43,866 grant awards under 93.853 have obligated $45,545,088,435 in federal funds to 1,425 recipients.
Who receives the most funding from 93.853?
The recipients obligated the most under Extramural Research Programs in the Neurosciences and Neurological Disorders are The General Hospital Corporation ($1,309,596,942), The Regents Of The University Of California. San Francisco ($1,204,076,115) and The Johns Hopkins University ($1,055,413,992).
How much did 93.853 obligate in fiscal year 2025?
Grants under 93.853 obligated $2,823,147,077 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.853?
40 of the latest 50 opportunities under 93.853 are open or forecasted. The latest, Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required), was posted on September 23, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program